2300159 | Bmd61 | Bone mineral density QTL 61 | 5.3 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 27597761 | Rat |
2300183 | Bmd60 | Bone mineral density QTL 60 | 5.7 | 0.0001 | femur mineral mass (VT:0010011) | volumetric bone mineral density (CMO:0001553) | 14 | 1 | 27597761 | Rat |
619619 | Rf4 | Renal disease susceptibility QTL 4 | 4.1 | 0.002 | total urine protein amount (VT:0000032) | urine protein excretion rate to body weight ratio (CMO:0001099) | 14 | 1 | 34403399 | Rat |
9589814 | Gluco67 | Glucose level QTL 67 | 4.54 | 0.001 | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 1 | 41333960 | Rat |
7411573 | Bw139 | Body weight QTL 139 | 4.7 | 0.001 | body mass (VT:0001259) | body weight gain (CMO:0000420) | 14 | 1 | 41333960 | Rat |
634352 | Apr6 | Acute phase response QTL 6 | 3.7 | | blood interleukin-6 amount (VT:0008595) | plasma interleukin-6 level (CMO:0001927) | 14 | 1 | 42766285 | Rat |
1300114 | Srn2 | Serum renin concentration QTL 2 | 3.27 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 4833233 | 23004027 | Rat |
70195 | Mcs8 | Mammary carcinoma susceptibility QTL 8 | 4.28 | | mammary gland integrity trait (VT:0010552) | mammary tumor number (CMO:0000343) | 14 | 4833233 | 26466248 | Rat |
1331740 | Bw26 | Body weight QTL 26 | 3.028 | | body mass (VT:0001259) | body weight (CMO:0000012) | 14 | 4833233 | 33040042 | Rat |
1581500 | Renag1 | Renal agenesis QTL 1 | | | kidney development trait (VT:0000527) | percentage of study population developing unilateral renal agenesis during a period of time (CMO:0000940) | 14 | 9756435 | 72854397 | Rat |
1358296 | Ael3 | Aortic elastin QTL 3 | 3.7 | 0.00051 | aorta elastin amount (VT:0003905) | aortic elastin | 14 | 10539977 | 55539977 | Rat |
2302045 | Pia39 | Pristane induced arthritis QTL 39 | 4.9 | 0.001 | blood immunoglobulin amount (VT:0002460) | serum immunoglobulin G2a level (CMO:0002116) | 14 | 10539977 | 55539977 | Rat |
731183 | Pia20 | Pristane induced arthritis QTL 20 | 3.55 | | joint integrity trait (VT:0010548) | joint inflammation composite score (CMO:0000919) | 14 | 10729268 | 61873323 | Rat |
2302277 | Gluco38 | Glucose level QTL 38 | 5.8 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 12680424 | 30155192 | Rat |
631839 | Niddm37 | Non-insulin dependent diabetes mellitus QTL 37 | 3.37 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 14 | 12680424 | 106641756 | Rat |
631212 | Bw5 | Body weight QTL5 | 5.43 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 14 | 12680613 | 32593926 | Rat |
1300140 | Srn3 | Serum renin concentration QTL 3 | 3.19 | | blood renin amount (VT:0003349) | plasma renin activity level (CMO:0000116) | 14 | 16336988 | 33163485 | Rat |
631528 | Scl11 | Serum cholesterol level QTL 11 | 4.9 | | blood cholesterol amount (VT:0000180) | blood total cholesterol level (CMO:0000051) | 14 | 19159919 | 38289187 | Rat |
71117 | Niddm17 | Non-insulin dependent diabetes mellitus QTL 17 | 2.35 | | blood glucose amount (VT:0000188) | plasma glucose level (CMO:0000042) | 14 | 19161893 | 43957503 | Rat |
631262 | Tcas4 | Tongue tumor susceptibility QTL 4 | 7.29 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 14 | 19191541 | 43957628 | Rat |
2313397 | Coatc1 | Coat color QTL1 | | | coat/hair pigmentation trait (VT:0010463) | coat/hair color measurement (CMO:0001808) | 14 | 20189386 | 65189386 | Rat |
61420 | Pia6 | Pristane induced arthritis QTL 6 | 4.9 | | joint integrity trait (VT:0010548) | arthritic paw count (CMO:0001460) | 14 | 20266223 | 43957628 | Rat |
10755459 | Coatc15 | Coat color QTL 15 | | 0.01681 | coat/hair pigmentation trait (VT:0010463) | pigmented ventral coat/hair area to total ventral coat/hair area ratio (CMO:0001812) | 14 | 21457565 | 66457565 | Rat |